Quarterly report · Q1
3353.TEDINET S100REIO
Period2023-03-01 → 2023-05-31
Filed2023-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥33.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2022-03-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥294m | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥239m | 2022-03-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥338m | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥313m | 2022-03-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥375m | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥334m | 2022-03-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥212m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥760m | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥208m | 2022-03-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥224m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥213m | 2022-03-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥28.1bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥28.8bn | at 2022-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.4bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥14.9bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥12.7bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥12.0bn | at 2022-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| EPS (basic) | ¥56.42 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥202.2 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.39 | 2022-03-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.8% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥187m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥375m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥810m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥275m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥23m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥47m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-05-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-05-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥277m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-05-31 | ¥481m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-05-31 | −¥253m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-05-31 | −¥253m |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-05-31 | −¥189m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥363m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥19m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥946m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥694m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥252m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥16m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥49m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥49m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥381,000 |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥30m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2022-05-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2022-05-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥253m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2022-05-31 | ¥428m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes payable | Prior1YearInstant | 189206000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 175094000 | JPY |
| Provision for bonuses | Prior1YearInstant | 222824000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 408470000 | JPY |
| Other cl | Prior1YearInstant | 738919000 | JPY |
| Other cl | CurrentQuarterInstant | 878619000 | JPY |
| Current liabilities | Prior1YearInstant | 7454768000 | JPY |
| Current liabilities | CurrentQuarterInstant | 7960108000 | JPY |
| Long term loans payable | Prior1YearInstant | 6062910000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 6065647000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 189717000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 182195000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 802137000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 810089000 | JPY |
| Other ncl | Prior1YearInstant | 388400000 | JPY |
| Other ncl | CurrentQuarterInstant | 362441000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 7443165000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 7420374000 | JPY |
| Liabilities | Prior1YearInstant | 14897934000 | JPY |
| Liabilities | CurrentQuarterInstant | 15380482000 | JPY |
| Capital stock | Prior1YearInstant | 917000000 | JPY |
| Capital stock | CurrentQuarterInstant | 917000000 | JPY |
| Capital surplus | Prior1YearInstant | 1081272000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1081272000 | JPY |
| Retained earnings | Prior1YearInstant | 10557964000 | JPY |
| Retained earnings | CurrentQuarterInstant | 10694797000 | JPY |
| Treasury stock | Prior1YearInstant | -539830000 | JPY |
| Treasury stock | CurrentQuarterInstant | -539830000 | JPY |
| Shareholders equity | Prior1YearInstant | 12016406000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 12153238000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 27858000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | -26774000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 5068000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 3801000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 32926000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | -22973000 | JPY |
| Non controlling interests | Prior1YearInstant | 558509000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 570447000 | JPY |
| Net assets | Prior1YearInstant | 12607842000 | JPY |
| Net assets | CurrentQuarterInstant | 12700712000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 27505776000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 28081195000 | JPY |
| Net sales | Prior1YTDDuration | 8563675000 | JPY |
| Net sales | CurrentYTDDuration | 8721952000 | JPY |
| Cost of sales | Prior1YTDDuration | 7742886000 | JPY |
| Cost of sales | CurrentYTDDuration | 7853429000 | JPY |
| Gross profit | Prior1YTDDuration | 820788000 | JPY |
| Gross profit | CurrentYTDDuration | 868523000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 581737000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 574120000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |